NCT04462471 2025-09-08Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid CancersMemorial Sloan Kettering Cancer CenterPhase 1 Completed8 enrolled 8 charts
NCT03469011 2025-06-27A Study to Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer.AHS Cancer Control AlbertaPhase 1 Terminated14 enrolled